David G. Jones

Covalent targeted radioligands potentiate radionuclide therapy

Computational approaches streamlining drug discovery

2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2′,3′:4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonists

Generation and screening of an oligonucleotide-encoded synthetic peptide library.